ANDA 90463, held by Apotex. Perindopril Erbumine.
As of Nov 16, 2026, ANDA 90463 (Perindopril Erbumine), held by Apotex, was first approved by FDA on Aug 30, 2010, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 30, 2010 | Original application | Approved | None posted |
| Perindopril Erbumine2MG · tablet;oral | Perindopril Erbumine | Discontinued |
| Perindopril Erbumine4MG · tablet;oral | Perindopril Erbumine | Discontinued |
| Perindopril Erbumine8MG · tablet;oral | Perindopril Erbumine | Discontinued |
| Apr 15, 2015 | Supplement 1Labeling · Standard review | Approved | None posted |
| Aug 30, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters